Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib.
Inanc N, Abacar KY, Ozturk MA, Tufan A, Karadeniz H, Sari I, Can G, Erez Y, Pehlivan Y, Dalkilic HE, Ocak T, Cefle A, Yazici A, Senel AS, Akar S, Durak-Ediboğlu E, Koca SS, Piskin-Sagir R, Yilmaz S, Gulcemal S, Soysal-Gunduz O, Basibuyuk CS, Alkan S, Cesur TY, Onen F. Inanc N, et al. Among authors: durak ediboglu e. J Clin Rheumatol. 2023 Dec 1;29(8):365-369. doi: 10.1097/RHU.0000000000002026. Epub 2023 Sep 19. J Clin Rheumatol. 2023. PMID: 37724891 Free PMC article.
Validity and reliability of the Turkish version of Exercise Benefits/ Barriers Scale: Perceived exercise benefits and barriers of patients with different axial spondyloarthritis subtypes.
Sarac DC, Durak Ediboglu E, Ozer Kaya D, Duran G, Akatay EA, Gucenmez S, Akar S, Bayraktar D. Sarac DC, et al. Among authors: durak ediboglu e. Arch Rheumatol. 2024 Aug 26;39(3):447-458. doi: 10.46497/ArchRheumatol.2024.10720. eCollection 2024 Sep. Arch Rheumatol. 2024. PMID: 39507848 Free PMC article.
Factors Associated with the Development of Anti-drug Antibodies to TNFi and the Consequences for Axial Spondyloarthritis: A Two-year Follow-up Study.
Durak Ediboğlu E, Çınar M, Kozacı D, Solmaz D, Sargın G, Karadağ Ö, Kınıklı G, Kalyoncu U, Yılmaz S, Şentürk T, Kabadayı G, Keser G, Hatemi G, Kaya K, Özmen M, Yargucu F, Özgüler Y, Cefle A, Gerçik Ö, Kısacık B, Akar S. Durak Ediboğlu E, et al. Eur J Rheumatol. 2024 Oct 14;11(3):364-370. doi: 10.5152/eurjrheum.2024.24013. Eur J Rheumatol. 2024. PMID: 39479725 Free PMC article.
IL-1 blocking experience in a case with Majeed syndrome diagnosed in adulthood.
Güleç Yazır M, Durak Ediboğlu E, Kabadayı G, Subaşıoğlu A, Akar S. Güleç Yazır M, et al. Among authors: durak ediboglu e. Z Rheumatol. 2024 Mar;83(2):139-141. doi: 10.1007/s00393-023-01465-9. Epub 2023 Dec 18. Z Rheumatol. 2024. PMID: 38108867 English. No abstract available.